Equities

Midsona AB

Midsona AB

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (SEK)12.00
  • Today's Change0.00 / 0.00%
  • Shares traded36.00
  • 1 Year change+21.21%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Midsona AB, formerly Midelfart Sonesson AB is a Sweden-based company engaged in the development, manufacture and marketing of consumer healthcare products in the Nordic region. Its products are divided into three product areas: Healthfoods, Hygiene, Personal Care. The Company consists of three geographical areas, namely Sweden, Norway and Finland. The business areas in Sweden, Norway and Finland market and sell nutritional supplements, herbal remedies, health foods, skin care and beauty products to grocery stores, pharmacies and health stores in respective geographic markets. The Company has several priority brands, such as Friggs, Urtekram, Naturdiet, Miwana, MyggA, Dalblads, Tri Tolonen, Supernature.

  • Revenue in SEK (TTM)3.77bn
  • Net income in SEK31.00m
  • Incorporated1984
  • Employees774.00
  • Location
    Midsona ABDockplatsen 16, Box 21009MALMO 200 21SwedenSWE
  • Phone+46 406018200
  • Fax+46 406018201
  • Websitehttps://www.midsona.se/
More ▼

Institutional shareholders

0.81%Per cent of shares held by top holders
HolderShares% Held
Swedbank Robur Fonder ABas of 31 May 20242.15k0.51%
Dimensional Fund Advisors Ltd.as of 31 May 20241.28k0.30%
Dimensional Fund Advisors LPas of 31 Aug 20240.000.00%
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.